268 related articles for article (PubMed ID: 18801070)
1. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
2. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
3. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.
Lee CH; Xue H; Sutcliffe M; Gout PW; Huntsman DG; Miller DM; Gilks CB; Wang YZ
Gynecol Oncol; 2005 Jan; 96(1):48-55. PubMed ID: 15589579
[TBL] [Abstract][Full Text] [Related]
4. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
5. Establishment of human tumor xenografts in immunodeficient mice.
Morton CL; Houghton PJ
Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone.
Yonou H; Yokose T; Kamijo T; Kanomata N; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2001 Mar; 61(5):2177-82. PubMed ID: 11280783
[TBL] [Abstract][Full Text] [Related]
7. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
[TBL] [Abstract][Full Text] [Related]
8. [Establishment and application of engrafted tumor models with humanized tumor blood vessel].
Ran YL; Zhong X; Hu H; Yu L; Lou JN; Yang ZH
Ai Zheng; 2006 Nov; 25(11):1323-8. PubMed ID: 17094895
[TBL] [Abstract][Full Text] [Related]
9. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human ovarian carcinomas in a SCID mouse model.
Xu Y; Silver DF; Yang NP; Oflazoglu E; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):161-70. PubMed ID: 10021295
[TBL] [Abstract][Full Text] [Related]
11. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Ruka W; Suit HD
Cancer Res; 1993 Oct; 53(20):5012-7. PubMed ID: 8402692
[TBL] [Abstract][Full Text] [Related]
12. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.
Abe T; Tada M; Shinohara N; Okada F; Itoh T; Hamada J; Harabayashi T; Chen Q; Moriuchi T; Nonomura K
Int J Urol; 2006 Jan; 13(1):47-57. PubMed ID: 16448432
[TBL] [Abstract][Full Text] [Related]
14. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/gamma c(null) immunodeficient mice.
Masuda H; Maruyama T; Hiratsu E; Yamane J; Iwanami A; Nagashima T; Ono M; Miyoshi H; Okano HJ; Ito M; Tamaoki N; Nomura T; Okano H; Matsuzaki Y; Yoshimura Y
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1925-30. PubMed ID: 17261813
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and characterization of three transplantable tumors of nasopharyngeal carcinoma in Scid mice].
Chen Z; Li D; Zhou L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):324-6. PubMed ID: 11986716
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
[TBL] [Abstract][Full Text] [Related]
18. Establishment of the hu-PBL-SCID mouse model for the investigation of thyroid cancer.
Gyory F; Mezosi E; Szakall S; Bajnok L; Varga E; Borbely A; Gazdag A; Juhasz I; Lukacs G; Nagy EV
Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):359-64. PubMed ID: 16025395
[TBL] [Abstract][Full Text] [Related]
19. Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment.
Balys R; Alaoui-Jamali M; Hier M; Black M; Domanowski G; Rochon L; Jie S
J Otolaryngol; 2006 Jun; 35(3):157-66. PubMed ID: 16929991
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice.
Dewan MZ; Watanabe M; Ahmed S; Terashima K; Horiuchi S; Sata T; Honda M; Ito M; Watanabe T; Horie R; Yamamoto N
Cancer Sci; 2005 Aug; 96(8):466-73. PubMed ID: 16108827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
